Literature DB >> 25487010

An overview of naturally occurring histone deacetylase inhibitors.

Bumki Kim, Jiyong Hong1.   

Abstract

Histone deacetylases (HDACs) have recently emerged as key elements in epigenetic control of gene expression. Due to the implication of HDACs in a variety of diseases ranging from cancer to neurodegenerative disorder, HDAC inhibitors have received increased attention in recent years. Over the last few decades, a myriad of HDAC inhibitors containing a wide variety of structural features have been identified from natural sources. Here, we review the discovery, synthesis, biological properties, and modes of action of these naturally occurring HDAC inhibitors and consider their implications for future research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25487010      PMCID: PMC6805157          DOI: 10.2174/1568026615666141208105614

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  127 in total

Review 1.  Deacetylase enzymes: biological functions and the use of small-molecule inhibitors.

Authors:  Christina M Grozinger; Stuart L Schreiber
Journal:  Chem Biol       Date:  2002-01

2.  AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase.

Authors:  Satoshi Sasamura; Kazutoshi Sakamoto; Shoji Takagaki; Toshiko Yamada; Shigehiro Takase; Hiroaki Mori; Takashi Fujii; Motohiro Hino; Michizane Hashimoto
Journal:  J Antibiot (Tokyo)       Date:  2010-06-30       Impact factor: 2.649

3.  Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.

Authors:  Kanchan Taori; Valerie J Paul; Hendrik Luesch
Journal:  J Am Chem Soc       Date:  2008-01-19       Impact factor: 15.419

4.  FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. II. Structure determination.

Authors:  N Shigematsu; H Ueda; S Takase; H Tanaka; K Yamamoto; T Tada
Journal:  J Antibiot (Tokyo)       Date:  1994-03       Impact factor: 2.649

Review 5.  Development and therapeutic implications of selective histone deacetylase 6 inhibitors.

Authors:  Jay H Kalin; Joel A Bergman
Journal:  J Med Chem       Date:  2013-05-15       Impact factor: 7.446

6.  A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells.

Authors:  Lalji K Gediya; Pankaj Chopra; Puranik Purushottamachar; Neha Maheshwari; Vincent C O Njar
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

7.  Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures.

Authors:  Ana Montero; John M Beierle; Christian A Olsen; M Reza Ghadiri
Journal:  J Am Chem Soc       Date:  2009-03-04       Impact factor: 15.419

8.  Structure elucidation and antimalarial activity of apicidin F: an apicidin-like compound produced by Fusarium fujikuroi.

Authors:  Katharina Walburga von Bargen; Eva-Maria Niehaus; Klaus Bergander; Reto Brun; Bettina Tudzynski; Hans-Ulrich Humpf
Journal:  J Nat Prod       Date:  2013-11-06       Impact factor: 4.050

Review 9.  Epigenetics in human disease and prospects for epigenetic therapy.

Authors:  Gerda Egger; Gangning Liang; Ana Aparicio; Peter A Jones
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

10.  Highly ligand efficient and selective N-2-(Thioethyl)picolinamide histone deacetylase inhibitors inspired by the natural product psammaplin A.

Authors:  Matthias G J Baud; Patricia Haus; Thomas Leiser; Franz-Josef Meyer-Almes; Matthew J Fuchter
Journal:  ChemMedChem       Date:  2012-11-26       Impact factor: 3.466

View more
  11 in total

Review 1.  Histone Deacetylase Inhibitors: A Prospect in Drug Discovery.

Authors:  Rakesh Yadav; Pooja Mishra; Divya Yadav
Journal:  Turk J Pharm Sci       Date:  2018-12-31

2.  Synthesis and biological evaluation of largazole zinc-binding group analogs.

Authors:  Bumki Kim; Ranjala Ratnayake; Hyunji Lee; Guqin Shi; Sabrina L Zeller; Chenglong Li; Hendrik Luesch; Jiyong Hong
Journal:  Bioorg Med Chem       Date:  2017-04-04       Impact factor: 3.641

3.  Cyclic Tetrapeptide HDAC Inhibitors with Improved Plasmodium falciparum Selectivity and Killing Profile.

Authors:  Jennifer E Collins; Jin Woo Lee; Monica J Bohmer; Joshua D Welden; Arash K Arshadi; Lin Du; Robert H Cichewicz; Debopam Chakrabarti
Journal:  ACS Infect Dis       Date:  2021-09-07       Impact factor: 5.578

4.  Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites.

Authors:  Paris R Watson; Timothy W Craven; Xinting Li; Stephen Rettie; Parisa Hosseinzadeh; Fátima Pardo-Avila; Asim K Bera; Vikram Khipple Mulligan; Peilong Lu; Alexander S Ford; Brian D Weitzner; Lance J Stewart; Adam P Moyer; Maddalena Di Piazza; Joshua G Whalen; Per Jr Greisen; David W Christianson; David Baker
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

5.  The nature of the GRE influences the screening for GR-activity enhancing modulators.

Authors:  Karen Dendoncker; Steven Timmermans; Kelly Van Looveren; Lode De Cauwer; Karolien De Bosscher; Claude Libert
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

6.  Inhibition of Histone Methyltransferase, Histone Deacetylase, and β-Catenin Synergistically Enhance the Cardiac Potential of Bone Marrow Cells.

Authors:  Jinpu Yang; Keerat Kaur; John G Edwards; Carol A Eisenberg; Leonard M Eisenberg
Journal:  Stem Cells Int       Date:  2017-07-16       Impact factor: 5.443

7.  Structure-activity relationship of ipglycermide binding to phosphoglycerate mutases.

Authors:  Mareike Wiedmann; Patricia K Dranchak; Mahesh Aitha; Bryan Queme; Christopher D Collmus; Maithri M Kashipathy; Liza Kanter; Laurence Lamy; Joseph M Rogers; Dingyin Tao; Kevin P Battaile; Ganesha Rai; Scott Lovell; Hiroaki Suga; James Inglese
Journal:  J Biol Chem       Date:  2021-04-01       Impact factor: 5.157

Review 8.  The Multifaceted Neurotoxicity of Astrocytes in Ageing and Age-Related Neurodegenerative Diseases: A Translational Perspective.

Authors:  David S Bouvier; Sonja Fixemer; Tony Heurtaux; Félicia Jeannelle; Katrin B M Frauenknecht; Michel Mittelbronn
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

Review 9.  Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders.

Authors:  Thayse Pinheiro da Costa; Marcia Cury El-Cheikh; Katia Carneiro
Journal:  J Immunol Res       Date:  2020-02-08       Impact factor: 4.818

Review 10.  Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention.

Authors:  Dusan Ruzic; Nemanja Djoković; Tatjana Srdić-Rajić; Cesar Echeverria; Katarina Nikolic; Juan F Santibanez
Journal:  Pharmaceutics       Date:  2022-01-16       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.